User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.

Primary tabs

Osselaer, Jean-Claude [UCL] Doyen, Chantal [UCL] Defoin, Laurence Debry, Cecile Goffaux, Maité Bosly, André [UCL] Corash, Laurence

BACKGROUND: Pathogen inactivation of platelet (PLT) components (INTERCEPT Blood System, Cerus Europe) was implemented into routine practice at a blood center supporting a tertiary care hospital. Utilization of platelet components (PCs) and red blood cell (RBC) components was analyzed for 3 years before and 3 years after introduction of pathogen inactivation to assess the impact of pathogen inactivation on component use. STUDY DESIGN AND METHODS: This was a retrospective analysis of prospectively collected data. An electronic database used in routine blood bank hemovigilance to monitor production and use of blood components was analyzed to assess clinical outcomes. RESULTS: Transfusion records were analyzed for 688 patients supported with conventional PCs and 795 patients supported with pathogen inactivation PCs. Additional analyses were conducted for intensively transfused hematology patients. Patient demographics (age category, sex, and diagnostic category) were not different in the two observation periods. For all patients, mean numbers of PC per patient were not different for conventional PCs and pathogen inactivation PCs (9.9 +/- 19.5 vs. 10.1 +/- 20.9, p = 0.88). Data for hematology patients (272 conventional PCs and 276 pathogen inactivation PCs) confirmed that days of PLT support were not different (31.6 +/- 42.6 vs. 33.1 +/- 47.9, p = 0.70) nor was total PLT dose (10(11)) per patient (87.3 +/- 115.4 vs. 88.1 +/- 111.6, p = 0.93). RBC use, for all patients and hematology patients, was not different in the two observation periods, either during periods of PLT support or outside periods of PLT transfusion support. CONCLUSION: Pathogen inactivation of PCs had no adverse impact on component use during a 3-year observation period of routine practice.

Document type Article de périodique (Journal article) – Journal Article
Access type Accès restreint
Publication date 2009
Journal information "Transfusion" - Vol. 49, no. 7, p. 1412-22 (2009)
Peer reviewed yes
issn 0041-1132
e-issn 1537-2995
Publication status Publié
Affiliations UCL - MD/MINT - Département de médecine interne
UCL - (MGD) Centre de transfusion sanguine
UCL - (MGD) Service d'hématologie
MESH Subject Retrospective Studies ; Platelet Transfusion - methods ; Platelet Count ; Humans ; Blood-Borne Pathogens ; Blood Preservation - methods ; Blood Platelets - drug effects - microbiology ; Blood Component Transfusion - methods
Links
  1. Harris, Blood banking and transfusion medicine, 183 (2007)
  2. Blajchman, Transfus Med Rev, 19, 259 (2005)
  3. Rebulla, N Engl J Med, 337, 1870 (1997)
  4. TRAP Study Group, N Engl J Med, 337, 1861 (1997)
  5. Tinmouth, Transfus Med Rev, 17, 181 (2003)
  6. Slichter, J Clin Apher, 21, 78 (2006)
  7. Slichter, American Society of Hematology education program book, 172 (2007)
  8. Osselaer, Vox Sang, 91, 180 (2006)
  9. 9.  Cazenave JP . Proceedings of a consensus conference: pathogen inactivation-making decisions about new technologies. Clinical experience with pathogen-inactivated platelets. Transfusion Med Reviews 2008;22:1-34.
  10. Klein, Transfusion, 47, 2338 (2007)
  11. van Rhenen, Blood, 101, 2426 (2003)
  12. McCullough, Blood, 104, 1534 (2004)
  13. Janetzko, Transfusion, 45, 1443 (2005)
  14. 14. Belgian Law of 8 December 1992 on privacy protection in relation to the processing of personal data as modified by the law of 11 December 1998 implementing Directive 95/46 EC and the law of 26 February 2003. Belgium: Belgian State Gazette; 2003.
  15. Snyder, Transfusion, 44, 1732 (2004)
  16. Murphy, Transfusion, 46, 24 (2006)
  17. Osselaer, Vox Sang, 94, 315 (2008)
  18. Osselaer, Transfusion, 48, 1061 (2008)
Bibliographic reference Osselaer, Jean-Claude ; Doyen, Chantal ; Defoin, Laurence ; Debry, Cecile ; Goffaux, Maité ; et. al. Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.. In: Transfusion, Vol. 49, no. 7, p. 1412-22 (2009)
Permanent URL http://hdl.handle.net/2078.1/22290